Patents Assigned to EyeServ GmbH
  • Gene therapy for the treatment of a retinal degeneration disease
    Patent number: 11400167
    Abstract: The present invention relates to a polynucleotide configured for the treatment of a retinal degeneration disease, such as retinitis pigmentosa (RP), a nucleic acid vector comprising said polynucleotide, a pharmaceutical composition comprising said nucleic acid vector, a kit comprising said polynucleotide or said nucleic acid vector, a method of making said nucleic acid vector, and a method for treating a retinal degeneration disease.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: August 2, 2022
    Assignee: EYESERV GMBH
    Inventors: Stylianos Michalakis, Martin Biel, Mathias Seeliger, Christian Schoen
  • Gene therapy for the treatment of a disease of retinal cone cells
    Patent number: 10849991
    Abstract: The present invention relates to a polynucleotide configured for the treatment of a disease of retinal cone cells, such as achromatopsia, a nucleic acid vector comprising said polynucleotide, a pharmaceutical composition comprising said nucleic acid vector, a kit comprising said polynucleotide or said nucleic acid vector, a method of making said nucleic acid vector, and a method for treating a disease of the retinal cone cells.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: December 1, 2020
    Assignee: EyeServ GmbH
    Inventors: Stylianos Michalakis, Martin Biel, Mathias Seeliger